New: NCI-funded clinical trial search
Mednet Logo

Does the presence of cribiform histology at biopsy in prostate cancer affect your management in an otherwise intermediate-risk prostate cancer?

Community PollStarted

Does the presence of cribiform histology at biopsy in prostate cancer affect your management in an otherwise intermediate-risk prostate cancer?

207 physicians have voted

Join Mednetto vote and see how they answered.

2 Answers
Mednet MemberInvited Expert
Radiation Oncology · UC San Diego
Answered on

There have been no trials on this specific question, so there is room for debate and more science (hoping our recent grant submission in this area gets funded...). Here is my current thinking. This is for generally healthy patients with long life expectancy (≥10 years, but especially if ≥15 years). And everything here applies to intraductal carcinoma (IDC), as well, as IDC was included in the definition of cribriform morphology in recent papers.

  1. No active surveillance for cribriform/IDC. Cribrif...

Join for free or sign in to see the full answer

Mednet Member
Urology · Center For Urology
Answered on

Here’s my opinion: A PSMA PET scan is important before deciding treatment options. Thanks to modern screening and more accurate staging at diagnosis, we have seen a stage shift toward earlier detection and clinically localized disease. If micrometastatic on PSMA PET, I recommend radiation and ADT. If high-volume metastasis, I recommend systemic therapy. If localized, most patients with a cribriform pattern are still successfully cured through surgical resection. I perform same-day discharge robo...

Join for free or sign in to see the full answer